Global Earnings Digest: Aspen Pharmacare NHEPS Plus 28 Percent, BBCP Raises Outlook on Data Center Boom

The Quick Take

• Aspen Pharmacare reported 28% NHEPS growth in FY26 and guided to over 50% NHEPS growth in FY27, driven by sterile manufacturing reshaping and a strong net cash position
• Concrete Pumping Holdings raised its full-year outlook and initiated a 5.6% dividend yield as US data center construction demand accelerated sharply
• Voltalia filed half-year results highlighting its European renewable energy pipeline alongside multiple smaller-cap earnings transcripts from Australia, UK and South Africa

Aspen Pharmacare's FY26 result stands out within this global earnings batch: a 28% NHEPS gain combined with guidance for over 50% growth in FY27 is exceptional by pharmaceutical sector standards, and reflects the completion of a multi-year sterile manufacturing transformation. The guidance increase signals that the FY27 pipeline of sterile pharmaceutical contracts is firm, reducing forward earnings risk that often accompanies ambitious guidance from transformation-phase pharma companies. Aspen's strong net cash position further reduces balance sheet risk at a time when global pharma peers are navigating elevated capital costs.

Concrete Pumping Holdings' 5.6% dividend yield initiation alongside a raised full-year outlook reflects how data center construction is creating durable volume support for specialized infrastructure services companies. Infrastructure investment themes — data centers, grid modernization, semiconductor fabrication — are generating sustained demand for construction services at a pace that management expects to continue through the fiscal year. For investors seeking diversified exposure to the AI infrastructure theme beyond semiconductor stocks, names like BBCP represent an unconventional but viable avenue.

Synthesized from 18 sources.